Skip to main content
Erschienen in: European Journal of Pediatrics 4/2017

17.02.2017 | Original Article

Screening for non-alcoholic fatty liver disease in children and adolescents with type 1 diabetes mellitus: a cross-sectional analysis

verfasst von: Sebastian Kummer, Dirk Klee, Gerald Kircheis, Michael Friedt, Joerg Schaper, Dieter Häussinger, Ertan Mayatepek, Thomas Meissner

Erschienen in: European Journal of Pediatrics | Ausgabe 4/2017

Einloggen, um Zugang zu erhalten

Abstract

The liver is intensely involved in glucose metabolism and is thereby closely related to diabetes pathophysiology. Adult patients with type 1 diabetes mellitus (DM) are at an increased risk for non-alcoholic fatty liver disease (NAFLD). Here, we studied the prevalence of NAFLD in a cohort of children and adolescents with type 1 DM in a tertiary care paediatric diabetes centre in Germany. We screened 93 children and adolescents with type 1 DM using ultrasound, laboratory investigations, and liver stiffness measurements (Fibroscan® [FS] and acoustic radiation force imaging [ARFI]). Of these, 82 (88.1%) had completely normal results in all examined aspects. Only one patient (1.1%) fulfilled the criteria as potential NAFLD with ALT > twice the upper limit of normal. Ten of the 93 patients (10.8%) showed any mild abnormality in at least one examined category including ALT, conventional ultrasounds and liver stiffness measurements. However, none of these ten fulfilled the NAFLD case definition criteria. Therefore, these slightly abnormal results were judged to be unspecific or at least of unknown significance in terms of NAFLD indication.
Conclusion: Compared to data from the general population, our results do not indicate a significantly increased prevalence of NAFLD in this cohort, and advocate against the systematic screening for NAFLD in paediatric type 1 DM.
What is Known:
• Non-alcoholic fatty liver disease (NAFLD) is common in adults with type 1 DM, and paediatric patients with type 1 DM in Egypt and Saudi Arabia.
What is New:
• Our results do not indicate a significantly increased prevalence of NAFLD in a cohort of children and adolescents with type 1 DM from Germany compared to prevalence data from the general population.
• This finding advocates against the systematic screening for NAFLD in paediatric type 1 DM in western countries.
Literatur
1.
2.
Zurück zum Zitat Carvalhana S, Leitão J, Alves AC, Bourbon M, Cortez-Pinto H (2014) How good is controlled attenuation parameter and fatty liver index for assessing liver steatosis in general population: correlation with ultrasound. Liver Int 34:e111–e117CrossRefPubMed Carvalhana S, Leitão J, Alves AC, Bourbon M, Cortez-Pinto H (2014) How good is controlled attenuation parameter and fatty liver index for assessing liver steatosis in general population: correlation with ultrasound. Liver Int 34:e111–e117CrossRefPubMed
3.
Zurück zum Zitat Craig ME, Jefferies C, Dabelea D, Balde N, Seth A, Donaghue KC, International Society for Pediatric and Adolescent Diabetes (2014) ISPAD Clinical Practice Consensus Guidelines 2014. Definition, epidemiology, and classification of diabetes in children and adolescents. Pediatr Diabetes 15(Suppl 2):4–17CrossRefPubMed Craig ME, Jefferies C, Dabelea D, Balde N, Seth A, Donaghue KC, International Society for Pediatric and Adolescent Diabetes (2014) ISPAD Clinical Practice Consensus Guidelines 2014. Definition, epidemiology, and classification of diabetes in children and adolescents. Pediatr Diabetes 15(Suppl 2):4–17CrossRefPubMed
4.
Zurück zum Zitat de Ledinghen V, Le Bail B, Rebouissoux L, Fournier C, Foucher J, Miette V, Castéra L, Sandrin L, Merrouche W, Lavrand F, Lamireau T (2007) Liver stiffness measurement in children using FibroScan: feasibility study and comparison with Fibrotest, aspartate transaminase to platelets ratio index, and liver biopsy. J Pediatr Gastroenterol Nutr 45:443–450CrossRefPubMed de Ledinghen V, Le Bail B, Rebouissoux L, Fournier C, Foucher J, Miette V, Castéra L, Sandrin L, Merrouche W, Lavrand F, Lamireau T (2007) Liver stiffness measurement in children using FibroScan: feasibility study and comparison with Fibrotest, aspartate transaminase to platelets ratio index, and liver biopsy. J Pediatr Gastroenterol Nutr 45:443–450CrossRefPubMed
5.
Zurück zum Zitat Elkabbany ZA, Elbarbary NS, Ismail EA, Mohamed NA, Ragab D, Abdel Alem S, Ezzat YM, Maurice SS, Hashem NU (2016) Transient elastography as a noninvasive assessment tool for hepatopathies of different etiology in pediatric type 1 diabetes mellitus. J Diabetes Complicat 31:186–194CrossRefPubMed Elkabbany ZA, Elbarbary NS, Ismail EA, Mohamed NA, Ragab D, Abdel Alem S, Ezzat YM, Maurice SS, Hashem NU (2016) Transient elastography as a noninvasive assessment tool for hepatopathies of different etiology in pediatric type 1 diabetes mellitus. J Diabetes Complicat 31:186–194CrossRefPubMed
6.
Zurück zum Zitat El-Karaksy HM, Anwar G, Esmat G, Mansour S, Sabry M, Helmy H, El-Hennawy A, Fouad H (2010) Prevalence of hepatic abnormalities in a cohort of Egyptian children with type 1 diabetes mellitus. Pediatr Diabetes 11:462–470CrossRefPubMed El-Karaksy HM, Anwar G, Esmat G, Mansour S, Sabry M, Helmy H, El-Hennawy A, Fouad H (2010) Prevalence of hepatic abnormalities in a cohort of Egyptian children with type 1 diabetes mellitus. Pediatr Diabetes 11:462–470CrossRefPubMed
7.
Zurück zum Zitat Engelmann G, Gebhardt C, Wenning D, Wühl E, Hoffmann GF, Selmi B, Grulich-Henn J, Schenk JP, Teufel U (2012) Feasibility study and control values of transient elastography in healthy children. Eur J Pediatr 171:353–360CrossRefPubMed Engelmann G, Gebhardt C, Wenning D, Wühl E, Hoffmann GF, Selmi B, Grulich-Henn J, Schenk JP, Teufel U (2012) Feasibility study and control values of transient elastography in healthy children. Eur J Pediatr 171:353–360CrossRefPubMed
8.
Zurück zum Zitat Farmer TD, Jenkins EC, O’Brien TP, McCoy GA, Havlik AE, Nass ER, Nicholson WE, Printz RL, Shiota M (2015) Comparison of the physiological relevance of systemic vs. portal insulin delivery to evaluate whole body glucose flux during an insulin clamp. Am J Physiol - Endocrinol Metab 308:E206–E222CrossRefPubMed Farmer TD, Jenkins EC, O’Brien TP, McCoy GA, Havlik AE, Nass ER, Nicholson WE, Printz RL, Shiota M (2015) Comparison of the physiological relevance of systemic vs. portal insulin delivery to evaluate whole body glucose flux during an insulin clamp. Am J Physiol - Endocrinol Metab 308:E206–E222CrossRefPubMed
9.
Zurück zum Zitat Fitzpatrick E, Cotoi C, Quaglia A, Sakellariou S, Ford-Adams ME, Hadzic N (2014) Hepatopathy of Mauriac syndrome: a retrospective review from a tertiary liver centre. Arch Dis Child 99:354–357CrossRefPubMed Fitzpatrick E, Cotoi C, Quaglia A, Sakellariou S, Ford-Adams ME, Hadzic N (2014) Hepatopathy of Mauriac syndrome: a retrospective review from a tertiary liver centre. Arch Dis Child 99:354–357CrossRefPubMed
10.
Zurück zum Zitat Fraser A, Longnecker MP, Lawlor DA (2007) Prevalence of elevated alanine aminotransferase among US adolescents and associated factors: NHANES 1999-2004. Gastroenterology 133:1814–1820CrossRefPubMedPubMedCentral Fraser A, Longnecker MP, Lawlor DA (2007) Prevalence of elevated alanine aminotransferase among US adolescents and associated factors: NHANES 1999-2004. Gastroenterology 133:1814–1820CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Friedrich-Rust M, Ong MF, Martens S, Sarrazin C, Bojunga J, Zeuzem S, Herrmann E (2008) Performance of transient elastography for the staging of liver fibrosis: a meta-analysis. Gastroenterology 134:960–974CrossRefPubMed Friedrich-Rust M, Ong MF, Martens S, Sarrazin C, Bojunga J, Zeuzem S, Herrmann E (2008) Performance of transient elastography for the staging of liver fibrosis: a meta-analysis. Gastroenterology 134:960–974CrossRefPubMed
13.
Zurück zum Zitat Hoyer PF, Vester U (2014) Leber. In: Deeg K-H, Hofmann V, Hoyer PF (eds) Ultraschalldiagnostik Pädiatrie und Kinderchirurgie, 4th edn. Thieme, Stuttgart, pp 581–649 Hoyer PF, Vester U (2014) Leber. In: Deeg K-H, Hofmann V, Hoyer PF (eds) Ultraschalldiagnostik Pädiatrie und Kinderchirurgie, 4th edn. Thieme, Stuttgart, pp 581–649
14.
Zurück zum Zitat Igawa K, Mugavero M, Shiota M, Neal DW, Cherrington AD (2002) Insulin sensitively controls the glucagon response to mild hypoglycemia in the dog. Diabetes 51:3033–3042CrossRefPubMed Igawa K, Mugavero M, Shiota M, Neal DW, Cherrington AD (2002) Insulin sensitively controls the glucagon response to mild hypoglycemia in the dog. Diabetes 51:3033–3042CrossRefPubMed
15.
Zurück zum Zitat Kircheis G, Sagir A, Vogt C, Vom Dahl S, Kubitz R, Häussinger D (2012) Evaluation of acoustic radiation force impulse imaging for determination of liver stiffness using transient elastography as a reference. World J Gastroenterol 18:1077–1084CrossRefPubMedPubMedCentral Kircheis G, Sagir A, Vogt C, Vom Dahl S, Kubitz R, Häussinger D (2012) Evaluation of acoustic radiation force impulse imaging for determination of liver stiffness using transient elastography as a reference. World J Gastroenterol 18:1077–1084CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Kummer S, Sagir A, Pandey S, Feldkötter M, Habbig S, Körber F, Ney D, Hoppe B, Häussinger D, Mayatepek E, Oh J (2010) Liver fibrosis in recessive multicystic kidney diseases: transient elastography for early detection. Pediatr Nephrol 26:725–731CrossRef Kummer S, Sagir A, Pandey S, Feldkötter M, Habbig S, Körber F, Ney D, Hoppe B, Häussinger D, Mayatepek E, Oh J (2010) Liver fibrosis in recessive multicystic kidney diseases: transient elastography for early detection. Pediatr Nephrol 26:725–731CrossRef
17.
Zurück zum Zitat Leeds JS, Forman EM, Morley S, Scott AR, Tesfaye S, Sanders DS (2009) Abnormal liver function tests in patients with type 1 diabetes mellitus: prevalence, clinical correlations and underlying pathologies. Diabet Med 26:1235–1241CrossRefPubMed Leeds JS, Forman EM, Morley S, Scott AR, Tesfaye S, Sanders DS (2009) Abnormal liver function tests in patients with type 1 diabetes mellitus: prevalence, clinical correlations and underlying pathologies. Diabet Med 26:1235–1241CrossRefPubMed
18.
Zurück zum Zitat Magkos F, Fabbrini E, Patterson BW, Eagon JC, Klein S (2011) Portal vein and systemic adiponectin concentrations are closely linked with hepatic glucose and lipoprotein kinetics in extremely obese subjects. Metabolism 60:1641–1648CrossRefPubMedPubMedCentral Magkos F, Fabbrini E, Patterson BW, Eagon JC, Klein S (2011) Portal vein and systemic adiponectin concentrations are closely linked with hepatic glucose and lipoprotein kinetics in extremely obese subjects. Metabolism 60:1641–1648CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ (1999) Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 116:1413–1419CrossRefPubMed Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ (1999) Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 116:1413–1419CrossRefPubMed
20.
Zurück zum Zitat Morral N, Edenberg HJ, Witting SR, Altomonte J, Chu T, Brown M (2007) Effects of glucose metabolism on the regulation of genes of fatty acid synthesis and triglyceride secretion in the liver. J Lipid Res 48:1499–1510CrossRefPubMed Morral N, Edenberg HJ, Witting SR, Altomonte J, Chu T, Brown M (2007) Effects of glucose metabolism on the regulation of genes of fatty acid synthesis and triglyceride secretion in the liver. J Lipid Res 48:1499–1510CrossRefPubMed
21.
22.
Zurück zum Zitat Nobili V, Vizzutti F, Arena U, Abraldes JG, Marra F, Pietrobattista A, Fruhwirth R, Marcellini M, Pinzani M (2008) Accuracy and reproducibility of transient elastography for the diagnosis of fibrosis in pediatric nonalcoholic steatohepatitis. Hepatology 48:442–448CrossRefPubMed Nobili V, Vizzutti F, Arena U, Abraldes JG, Marra F, Pietrobattista A, Fruhwirth R, Marcellini M, Pinzani M (2008) Accuracy and reproducibility of transient elastography for the diagnosis of fibrosis in pediatric nonalcoholic steatohepatitis. Hepatology 48:442–448CrossRefPubMed
23.
Zurück zum Zitat Petit JM, Pedro L, Guiu B, Duvillard L, Bouillet B, Jooste V, Habchi M, Crevisy E, Fourmont C, Buffier P et al (2015) Type 1 diabetes is not associated with an increased prevalence of hepatic steatosis. Diabet Med 32(12):1648–1651CrossRefPubMed Petit JM, Pedro L, Guiu B, Duvillard L, Bouillet B, Jooste V, Habchi M, Crevisy E, Fourmont C, Buffier P et al (2015) Type 1 diabetes is not associated with an increased prevalence of hepatic steatosis. Diabet Med 32(12):1648–1651CrossRefPubMed
24.
Zurück zum Zitat Regnell SE, Lernmark A (2011) Hepatic steatosis in type 1 diabetes. Rev Diabet Stud 8:454–467CrossRefPubMed Regnell SE, Lernmark A (2011) Hepatic steatosis in type 1 diabetes. Rev Diabet Stud 8:454–467CrossRefPubMed
25.
Zurück zum Zitat Regnell SE, Peterson P, Trinh L, Broberg P, Leander P, Lernmark A (2015) Magnetic resonance imaging reveals altered distribution of hepatic fat in children with type 1 diabetes compared to controls. Metabolism 64(8):872–878CrossRefPubMed Regnell SE, Peterson P, Trinh L, Broberg P, Leander P, Lernmark A (2015) Magnetic resonance imaging reveals altered distribution of hepatic fat in children with type 1 diabetes compared to controls. Metabolism 64(8):872–878CrossRefPubMed
26.
Zurück zum Zitat Rodríguez G, Gallego S, Breidenassel C, Moreno LA, Gottrand F (2010) Is liver transaminases assessment an appropriate tool for the screening of non-alcoholic fatty liver disease in at risk obese children and adolescents? Nutr Hosp 25:712–717PubMed Rodríguez G, Gallego S, Breidenassel C, Moreno LA, Gottrand F (2010) Is liver transaminases assessment an appropriate tool for the screening of non-alcoholic fatty liver disease in at risk obese children and adolescents? Nutr Hosp 25:712–717PubMed
27.
Zurück zum Zitat Sagir A, Ney D, Oh J, Pandey S, Kircheis G, Mayatepek E, Häussinger D (2015) Evaluation of acoustic radiation force impulse imaging (ARFI) for the determination of liver stiffness using transient elastography as a reference in children. Ultrasound Int Open 01:E2–E7CrossRef Sagir A, Ney D, Oh J, Pandey S, Kircheis G, Mayatepek E, Häussinger D (2015) Evaluation of acoustic radiation force impulse imaging (ARFI) for the determination of liver stiffness using transient elastography as a reference in children. Ultrasound Int Open 01:E2–E7CrossRef
28.
Zurück zum Zitat Saikusa M, Yatsuga S, Tonan T, Koga Y (2013) Glycogenic hepatopathy and non-alcoholic fatty liver disease in type 1 diabetes patients. Pediatr Int 55(6):806–807CrossRefPubMed Saikusa M, Yatsuga S, Tonan T, Koga Y (2013) Glycogenic hepatopathy and non-alcoholic fatty liver disease in type 1 diabetes patients. Pediatr Int 55(6):806–807CrossRefPubMed
29.
Zurück zum Zitat Schwimmer JB, Dunn W, Norman GJ, Pardee PE, Middleton MS, Kerkar N, Sirlin CB (2010) SAFETY study: alanine aminotransferase cutoff values are set too high for reliable detection of pediatric chronic liver disease. Gastroenterology 138:1357–1364CrossRefPubMedPubMedCentral Schwimmer JB, Dunn W, Norman GJ, Pardee PE, Middleton MS, Kerkar N, Sirlin CB (2010) SAFETY study: alanine aminotransferase cutoff values are set too high for reliable detection of pediatric chronic liver disease. Gastroenterology 138:1357–1364CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat Targher G, Bertolini L, Padovani R, Rodella S, Zoppini G, Pichiri I, Sorgato C, Zenari L, Bonora E (2010) Prevalence of non-alcoholic fatty liver disease and its association with cardiovascular disease in patients with type 1 diabetes. J Hepatol 53:713–718CrossRefPubMed Targher G, Bertolini L, Padovani R, Rodella S, Zoppini G, Pichiri I, Sorgato C, Zenari L, Bonora E (2010) Prevalence of non-alcoholic fatty liver disease and its association with cardiovascular disease in patients with type 1 diabetes. J Hepatol 53:713–718CrossRefPubMed
31.
Zurück zum Zitat Towbin AJ, Serai SD, Podberesky DJ (2013) Magnetic resonance imaging of the pediatric liver. Magn Reson Imaging Clin N Am 21:669–680CrossRefPubMed Towbin AJ, Serai SD, Podberesky DJ (2013) Magnetic resonance imaging of the pediatric liver. Magn Reson Imaging Clin N Am 21:669–680CrossRefPubMed
32.
Zurück zum Zitat Vos MB, Abrams SH, Barlow SE, Caprio S, Daniels SR, Kohli R, Mouzaki M, Sathya P, Schwimmer JB, Sundaram SS, Xanthakos SA (2017) NASPGHAN clinical practice guideline for the diagnosis and treatment of nonalcoholic fatty liver disease in children: recommendations from the expert committee on NAFLD (ECON) and the North American Society of Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN). J Pediatr Gastroenterol Nutr 64(2):319–334CrossRefPubMed Vos MB, Abrams SH, Barlow SE, Caprio S, Daniels SR, Kohli R, Mouzaki M, Sathya P, Schwimmer JB, Sundaram SS, Xanthakos SA (2017) NASPGHAN clinical practice guideline for the diagnosis and treatment of nonalcoholic fatty liver disease in children: recommendations from the expert committee on NAFLD (ECON) and the North American Society of Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN). J Pediatr Gastroenterol Nutr 64(2):319–334CrossRefPubMed
33.
Zurück zum Zitat West J, Brousil J, Gazis A, Jackson L, Mansell P, Bennett A, Aithal GP (2006) Elevated serum alanine transaminase in patients with type 1 or type 2 diabetes mellitus. QJM 99:871–876CrossRefPubMed West J, Brousil J, Gazis A, Jackson L, Mansell P, Bennett A, Aithal GP (2006) Elevated serum alanine transaminase in patients with type 1 or type 2 diabetes mellitus. QJM 99:871–876CrossRefPubMed
34.
Zurück zum Zitat Wiegand S, Keller K-M, Röbl M, L’Allemand D, Reinehr T, Widhalm K, Holl RW, APV Study Group and the German Competence Network Adipositas (2010) Obese boys at increased risk for nonalcoholic liver disease: evaluation of 16,390 overweight or obese children and adolescents. Int J Obes 34:1468–1474CrossRef Wiegand S, Keller K-M, Röbl M, L’Allemand D, Reinehr T, Widhalm K, Holl RW, APV Study Group and the German Competence Network Adipositas (2010) Obese boys at increased risk for nonalcoholic liver disease: evaluation of 16,390 overweight or obese children and adolescents. Int J Obes 34:1468–1474CrossRef
35.
Zurück zum Zitat Zhang HJ, Fe J, PanLL MZM, Han CK, Chen CS, Chen Z, Han HW, Chen S, Sun Q et al (2016) Effects of moderate and vigorous exercise on nonalcoholic fatty liver disease: a randomized clinical trial. JAMA Intern Med 176(8):1074–1082CrossRefPubMed Zhang HJ, Fe J, PanLL MZM, Han CK, Chen CS, Chen Z, Han HW, Chen S, Sun Q et al (2016) Effects of moderate and vigorous exercise on nonalcoholic fatty liver disease: a randomized clinical trial. JAMA Intern Med 176(8):1074–1082CrossRefPubMed
Metadaten
Titel
Screening for non-alcoholic fatty liver disease in children and adolescents with type 1 diabetes mellitus: a cross-sectional analysis
verfasst von
Sebastian Kummer
Dirk Klee
Gerald Kircheis
Michael Friedt
Joerg Schaper
Dieter Häussinger
Ertan Mayatepek
Thomas Meissner
Publikationsdatum
17.02.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Pediatrics / Ausgabe 4/2017
Print ISSN: 0340-6199
Elektronische ISSN: 1432-1076
DOI
https://doi.org/10.1007/s00431-017-2876-1

Weitere Artikel der Ausgabe 4/2017

European Journal of Pediatrics 4/2017 Zur Ausgabe

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.